InvestorsHub Logo
Followers 743
Posts 61848
Boards Moderated 10
Alias Born 10/05/2009

Re: boomer0921 post# 16422

Thursday, 07/02/2020 10:36:31 AM

Thursday, July 02, 2020 10:36:31 AM

Post# of 20017
There are no issued preferred shares issued yet.

Typically they would be used was control block voting shares for the shareholders bringing in the Biotech assets to protect their control of the assets for some period of time.

There are several ways the R/M asset owners could get sell-able shares but they would be restricted for a year according to my legal sources and then require SEC notices before they could be sold.

It is my current understanding that only the 290,000 float shares can be tradeable for a year once the SEC S-1/1-A filling is dropped.

"How does the prefered class A shares fit in to all this. It is on the list to be ticked off, and when would they be able to dilute those shares moving forward? "

But they have already been checked off by being created in the Nevada SOS fillings. Created but not issued. So that is a done item on the Shareholder letter also, and it said "create"... the class of preferred shares.

Only left on the shareholder letter is filling SEC fillings to go back to fully reporting.

Scams do not make shares vanish temporarily in a ticker and company change event. Scams print and dump trillions of shares to make money.

I Have not seen printed shares here NDT Pharmaceuticals land.










All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.